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The Editorial on the Research Topic
Biology of Cognitive Aging: Model Systems, Technologies, and Beyond
Age-related memory impairment (AMI), also called age-associated memory impairment (AAMI),
describes the normal emergence and progression of memory problems associated with aging. It
is one of diverse age-associated phenotypes found across a variety of organisms, including bees,
fruit flies, nematodes, snails, rodents, and humans. The goal of this editorial is to provide an
overview of our current understanding of AMI and its progression to more severe deficits related
to advanced age and dementia. This research issue focuses on model systems and technologies
relevant to cognitive aging and Alzheimer’s disease, and the study of AMI using invertebrate disease
models.
AMI can be viewed as a reduction in neuroplasticity, wherein the retention of existing
memories is relatively well-preserved, compared with the ability to acquire new information.
Aging specifically compromises mental processes underlying learning and some types of long-term
memory, while leaving other types of long-term and procedural memories intact. AMI, however,
may also include loss of existing memory, a condition termed age-related memory loss. In a
simplifiedmodel, cognitive aging can be described to occur in the following sequence: AMI (normal
state), mild cognitive impairment (MCI [transition state]), and then lastly, dementia (disease state).
The neural mechanisms underlying the development of AMI into more advanced age-related
disease remain unclear.
A wide variety of model systems and comparative analysis techniques show promise in guiding
therapeutic strategies for elderly patients with memory impairments. Despite their potential, the
use of disease models in this field of medicine has been discouraged. As stated by the Alzheimer’s
Association1, “a limitation of these models is that they do not capture the full complexity of
the human condition, which is problematic if one wants to use them to predict the success of
specific therapeutic interventions in individuals with Alzheimer’s disease (Accessed on Dec 2015).”
This research issue thoroughly discusses both the advantages and limitations of disease models of
cognitive aging.
A major aim of this editorial is to compile information about and identify connections between
patients with dementia and other organisms, such as bees (Farooqui), fruit flies (Mukherjee et al.),
nematodes (Alexander et al.; Gkikas et al.; Machino et al. ; Scerbak et al.; Therrien and Parker),
snails (Hermann et al.), fish (Newman et al.), and rodents (Webster et al.; Way et al.); a manuscript
co-authored by an early-stage patient with Alzheimer’s disease (Murakami and Halperin) is also
discussed. The work described herein includes rigorous reviews and original research articles
on models of Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, Amyotrophic lateral
1Alzheimer’s association. Areas of Focus for the 2014 International Research Grant Program. Available online at:
http://www.alz.org/research/downloads/2014_area_of_focus.pdf (Accessed on Dec 2015).
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sclerosis, and other neurodegenerative conditions. Alexander
et al. comprehensively review neurodegenerative disease in the
nematode, Caenorhabditis elegans (C. elegans), while Webster
et al. address the significance of mouse models to our
understanding of human Alzheimer’s disease. Gkikas et al.
discuss pathways of longevity that potentially restore memory
function during aging in C. elegans. Machino et al. propose the
use of a semi-automated motion-tracking system as a platform
for genetic and pharmacological screening, which was inspired
by feedback from an early-stage patient with Alzheimer’s disease
(Murakami and Halperin). The study of AMI and dementia also
utilizes other non-mammalian models, such as the freshwater
snail (Hermann et al.) and a zebra fish model of Alzheimer’s
disease (Newman et al.), among others.
Animal models enable functional analysis of AMI and
dementia and provide useful information for minimizing
the risks for humans. Thus, it would not be beneficial
to underestimate the role of model systems in medicine.
Additionally, research using such systems would be better
positioned to advance future therapies if patient feedback
is incorporated. To this end, Murakami and Halperin have
proposed soliciting feedback from patients in an effort to
align basic research with clinical practice, patient care, and the
patient experience. Such feedback emphasizes the importance
of existing comorbidities and potential interaction/association
between co-occurring diseases. This approach is consistent
with the “mid-life crisis theory,” in which earlier deleterious
events are associated with aging and later age-related diseases
(Murakami et al., 2011; Murakami, 2013).
I thank all of the authors for their contributions. I would
especially like to thankmy friend and collaborator, Dr. Alexander
“Sandy” Halperin, who, despite difficult personal circumstances,
continues to provide valuable insight from a patient’s point of
view.
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